Showing 33,581 - 33,600 results of 63,688 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((wt decrease) OR (we decrease)) ))', query time: 0.93s Refine Results
  1. 33581

    Image_8_OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis.tif by Longwei Xu (655781)

    Published 2022
    “…Activation of the OX40 pathway aggravates allergic diseases, such as asthma, but it is not clear whether OX40 is expressed in eosinophils to regulate inflammation in EGIDs. In this study, we assessed the expression and effect of OX40 on eosinophils in WT and Ox40<sup>-/-</sup> eosinophilic gastroenteritis (EGE) mice.…”
  2. 33582

    Image_7_OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis.tif by Longwei Xu (655781)

    Published 2022
    “…Activation of the OX40 pathway aggravates allergic diseases, such as asthma, but it is not clear whether OX40 is expressed in eosinophils to regulate inflammation in EGIDs. In this study, we assessed the expression and effect of OX40 on eosinophils in WT and Ox40<sup>-/-</sup> eosinophilic gastroenteritis (EGE) mice.…”
  3. 33583

    Image_1_OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis.tif by Longwei Xu (655781)

    Published 2022
    “…Activation of the OX40 pathway aggravates allergic diseases, such as asthma, but it is not clear whether OX40 is expressed in eosinophils to regulate inflammation in EGIDs. In this study, we assessed the expression and effect of OX40 on eosinophils in WT and Ox40<sup>-/-</sup> eosinophilic gastroenteritis (EGE) mice.…”
  4. 33584

    Image_4_OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis.tif by Longwei Xu (655781)

    Published 2022
    “…Activation of the OX40 pathway aggravates allergic diseases, such as asthma, but it is not clear whether OX40 is expressed in eosinophils to regulate inflammation in EGIDs. In this study, we assessed the expression and effect of OX40 on eosinophils in WT and Ox40<sup>-/-</sup> eosinophilic gastroenteritis (EGE) mice.…”
  5. 33585

    Image_6_OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis.tif by Longwei Xu (655781)

    Published 2022
    “…Activation of the OX40 pathway aggravates allergic diseases, such as asthma, but it is not clear whether OX40 is expressed in eosinophils to regulate inflammation in EGIDs. In this study, we assessed the expression and effect of OX40 on eosinophils in WT and Ox40<sup>-/-</sup> eosinophilic gastroenteritis (EGE) mice.…”
  6. 33586

    Image_2_OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis.tif by Longwei Xu (655781)

    Published 2022
    “…Activation of the OX40 pathway aggravates allergic diseases, such as asthma, but it is not clear whether OX40 is expressed in eosinophils to regulate inflammation in EGIDs. In this study, we assessed the expression and effect of OX40 on eosinophils in WT and Ox40<sup>-/-</sup> eosinophilic gastroenteritis (EGE) mice.…”
  7. 33587

    Data Sheet 1_miR-223 alleviates DSS-induced colitis by prompting macrophage M2 polarization through PPAR-γ/FOXO1 signaling.pdf by Juanjuan Zhang (432819)

    Published 2025
    “…Colitis was induced with 2.5% DSS for 7 days; miR-223 agomir or NC was administered intraperitoneally on days 2–4. …”
  8. 33588

    Data_Sheet_1_Tle4z1 Facilitate the Male Sexual Differentiation of Chicken Embryos.doc by Chen Chen (6544)

    Published 2022
    “…Furthermore, the expression of Cyp19a1, which dominates female differentiation, was significantly increased, while the expression of male marker genes Dmrt1, Sox9, WT1 and AR was significantly downregulated. In addition, the concentration of testosterone also significantly decreased, which was positively correlated with the expression of Tle4z1 (P < 0.01). …”
  9. 33589

    Clinical outcomes (MACE). by Tomohiko Shindo (612852)

    Published 2023
    “…The average weekly nitroglycerin use (times/week) was decreased from 5.50 to 2.44 in the LIPUS group and from 5.94 to 2.83 in the placebo group. …”
  10. 33590

    Baseline patient characteristics. by Tomohiko Shindo (612852)

    Published 2023
    “…The average weekly nitroglycerin use (times/week) was decreased from 5.50 to 2.44 in the LIPUS group and from 5.94 to 2.83 in the placebo group. …”
  11. 33591

    Clinical outcomes. by Tomohiko Shindo (612852)

    Published 2023
    “…The average weekly nitroglycerin use (times/week) was decreased from 5.50 to 2.44 in the LIPUS group and from 5.94 to 2.83 in the placebo group. …”
  12. 33592

    Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution by Refik Oltulu (5763947)

    Published 2018
    “…The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. …”
  13. 33593

    ADMET profile of screened compounds. by Aasia Kalsoom (18771234)

    Published 2024
    “…Our Morphological observation showed a significant difference in the cell morphology and proliferation potential which was decreased under the effect of plant extracts treatment as compared to the control samples. …”
  14. 33594

    Details of primers designed and ‘AZENTA’ IDs. by Aasia Kalsoom (18771234)

    Published 2024
    “…Our Morphological observation showed a significant difference in the cell morphology and proliferation potential which was decreased under the effect of plant extracts treatment as compared to the control samples. …”
  15. 33595

    Optimized thermal profile for qPCR. by Aasia Kalsoom (18771234)

    Published 2024
    “…Our Morphological observation showed a significant difference in the cell morphology and proliferation potential which was decreased under the effect of plant extracts treatment as compared to the control samples. …”
  16. 33596

    Grid box dimensions for target proteins. by Aasia Kalsoom (18771234)

    Published 2024
    “…Our Morphological observation showed a significant difference in the cell morphology and proliferation potential which was decreased under the effect of plant extracts treatment as compared to the control samples. …”
  17. 33597

    Properties of genetically regulated exon splicing, as revealed by ψQTL analysis. by Jonah Einson (18150072)

    Published 2024
    “…Using bulk RNA-seq data from GTEx V8, we mapped splicing quantitative trait loci using individual exon PSI as a molecular phenotype. …”
  18. 33598

    Table_1_Reduced Blood RGS2 Expression in Mild Cognitive Impairment Patients.XLSX by Elena Milanesi (668458)

    Published 2021
    “…We found that RGS2 was indeed downregulated in the peripheral blood of these patients (FR = −1.60, p < 0.001), and despite disease-specific therapy, RGS2 transcript levels continued to decrease at 1 year. The results suggest that RGS2 seems to be involved in AD pathology and progression and can be introduced in a panel of blood AD biomarkers.…”
  19. 33599

    Experimental and Modeling Study on Ignition Delay Times of Dimethyl Ether/Propane/Oxygen/Argon Mixtures at 20 bar by Erjiang Hu (1286775)

    Published 2015
    “…Ignition delay times of dimethyl ether (DME)/propane/oxygen/argon mixtures at a pressure of 20 bar were measured in a shock tube at different DME blending ratios (0, 20, 50, 80, and 100%), equivalence ratios (0.5, 1.0 and 2.0), and temperatures (1100–1500 K). …”
  20. 33600

    Concordant (green countries) and discordant (red countries) trends in MRSA BSI rates and glycopeptides use adjusted for trend in CoNS and VRE BSI rates in Europe in the study perio... by Beryl Primrose Gladstone (606879)

    Published 2017
    “…<p>The colours represent the European countries with <b>Red:</b> discordant trend between glycopeptide consumption and prevalence rate of BSI due to MRSA, VSE and CONS / a concordant trend with a difference of more than 100% between the relative increase in glycopeptide consumption and relative increase in prevalence rates; Discordant trend defined as opposing trends between between glycopeptide consumption and prevalence rate of BSI due to MRSA, VSE and CONS with a difference of more than 50% in relative increase / relative decrease; <b>Green:</b> concordant trend between the glycopeptide consumption and prevalence rates of BSI; <b>Yellow:</b> No information available.…”